Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Novus Biologicals™ KA1/GRIK4/Glutamate Receptor KA1 Antibody Blocking Peptide
Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
Supplier: Novus Biologicals™ NBP176852PEP
Description
A blocking peptide containing 14 amino acids near the amino terminus of human Grik4. Source: Synthetic (Accession #: Q16099) The KA1/GRIK4/Glutamate Receptor KA1 Blocking Peptide has been validated for the following applications: Antibody Competition.Specifications
2900 | |
Store at -20 C. Avoid freeze-thaw cycles. | |
This Peptide is Useful as a Blocking Peptide for NBP1-76852. For Further Blocking Peptide Related Protocol, Click Here . | |
GRIK4 | |
0.05 mg | |
Synthetic |
Human | |
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin. | |
EAA1, Excitatory amino acid receptor 1, glutamate receptor KA1, Glutamate receptor KA-1, glutamate receptor, ionotropic kainate 4, glutamate receptor, ionotropic, kainate 4, KA1GRIK | |
KA1/GRIK4/Glutamate Receptor KA1 | |
RUO - research use only | |
14 amino acids near the amino terminus of human Grik4 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction